Comparison of ACB With ACB and BiFeS Combination in Knee Arthroplasty Surgeries

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCumhuriyet University

About this trial

The aim is to compare the postoperative analgesic effects of Adductor Canal and Biceps Femoris Short Head Blocks with Adductor Canal Block in patients undergoing Knee Arthroplasty surgery

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients over 18 years of age who underwent percutaneous nephrolithotomy under general anesthesia and were I-II-III according to the American Society of Anesthesiologists (ASA) risk classification were included in the study.

Disqualifiers

patients who did not give consent,

patients with coagulopathy,

patients with signs of infection at the block application site,

patients using anticoagulants,

Trial design

Design model

Parallel

Treatments tested in this trial

  • Adductor Canal Block (ACB) Only

    Procedure/Surgery

    20 mL of 0.25% bupivacaine

  • Adductor Canal Block (ACB) + Biceps Femoris Short Head Block (BiFeS)

    Procedure/Surgery

    20 mL of 0.25% bupivacaine

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Adductor Canal BlockActive comparator 1 intervention
Group B: Combination of Adductor Canal Block and Biceps Femoris Short Head BlockActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

1. Numeric Rating Scale (NRS) Scores

Numerical rating scale is used for pain assessment. The scores of the numerical rating scale changes between 0 to 10 points. 10 points mean "the most severe pain that the patient ever had". 0 point means "there is no pain." Higher scores mean worse outcome.

Time frame
Postoperative 24 hours

Secondary outcomes

1

Total tramadol consumption

Postoperative total analgesic need was recorded as "milligram" in unit.

Time frame
Postoperative 24 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: